Reference
Hagiwara Y, et al. Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study. PharmacoEconomics : 17 Oct 2017. Available from: URL: http://dx.doi.org/10.1007/s40273-017-0580-7
Rights and permissions
About this article
Cite this article
AEs impact QOL in patients with metastatic breast cancer. PharmacoEcon Outcomes News 790, 4 (2017). https://doi.org/10.1007/s40274-017-4449-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4449-y